Quick Updates

Published: 11/07/2019 - 09:51

A new 10-year mapping review of the field of patient ergonomics, authored by Holden, Cornet, and Valdez, is now available from the journal Applied Ergonomics. For a limited time, the article can be accessed free of charge.

Published: 08/12/2019 - 21:13

HIL doctoral student Carly Daley, along with co-authors Monirah Al-Abdulmunem and Dr. Holden, led a paper published in top cardiology journal Heart & Lung. The paper, a systematic review of patient knowledge of heart failure, can be accessed here.

Published: 08/12/2019 - 20:43

Dr. Richard Holden and Dr. Rupa Valdez (U Virginia) were invited to organize a second town hall on Patient Ergonomics as part of the 2019 Annual Meeting of the Human Factors and Ergonomics Society in Seattle, Washington. The town hall follows a well attended 2018 town hall, the first ever on the topic of patient-centered human factors.

Published: 07/30/2019 - 11:08

At the inaugural Regenstrief Institute Startup Exploration (RISE) session, Dr. Holden presented his team's new app for dementia caregivers, Brain CareNotes.

Major Updates

Published: 02/13/2020 - 12:23

Dr. Holden is the Principal Investigator (PI) of a new project applying social network science to study and improve the change in medication safety awareness and behavior. The project is a partnership between the IU Center for Aging Research (Drs. Holden, Campbell, Boustani, and Monahan) and the IU Network Science Institute (Drs. Eddens, Krendl). Read more about the SNA-P project

Published: 11/07/2019 - 09:43

The R2D2 trial is an R01 led by Dr. Noll Campbell of the Purdue College of Pharmacy. It will test a pharmacy-based anticholinergic deprescribing intervention for older adults. Campbell co-directs the Brain Safety Lab with Dr. Holden.

Published: 11/07/2019 - 09:31

The two grants, the ICARE trial (R21, Holden and Boustani) and MOMENT trial (K23, Bateman) from the National Institute on Aging, will study whether use of the Brain CareNotes app is feasible, usable, and effective for reducing behavioral and psychological symptoms of dementia.

Published: 07/30/2019 - 11:17

Dr. Holden is the principal investigator of a newly funded $3.5M NIH award for a randomized controlled trial of Brain Safe, an intervention to reduce older adults' exposure to medications whose use is linked with dementia.